Definitions

11 та иш

Журнал

1. International Agency for Research on Cancer

   National Cancer Institute

   БошқаScience, Research, and MedicineDefinitions20206 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.000055

2. Flanvotumab

   National Cancer Institute

   БошқаCancer Immunotherapy and BiomarkersDefinitions20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.other.000087

3. Anetumab

   National Cancer Institute

   БошқаMyeloproliferative Neoplasms: Diagnosis and TreatmentDefinitions20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.other.000089

4. Narnatumab

   National Cancer Institute

   БошқаCancer Immunotherapy and BiomarkersDefinitions20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.other.000090

5. Catumaxomab

   National Cancer Institute

   БошқаMultiple Myeloma Research and TreatmentsDefinitions20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.other.000091

6. Ombitasvir

   National Cancer Institute

   БошқаSystemic Lupus Erythematosus ResearchDefinitions20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.other.000092

7. Gerbil Fibrosarcoma

   National Cancer Institute

   БошқаSarcoma Diagnosis and TreatmentDefinitions20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.other.000093

8. Anetumab Ravtansine

   National Cancer Institute

   БошқаMultiple Myeloma Research and TreatmentsDefinitions20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.other.000094

9. Ustilago maydis

   National Cancer Institute

   БошқаPlant Disease Resistance and GeneticsDefinitions20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.other.000095

10. Seribantumab

    National Cancer Institute

    БошқаNeutrophil, Myeloperoxidase and Oxidative MechanismsDefinitions20200 иқтибос

    ABIABI:AkademIndex/openalex/2020.other.000098

11. Gerbil Fibroma

    National Cancer Institute

    БошқаShoulder and Clavicle InjuriesDefinitions20200 иқтибос

    ABIABI:AkademIndex/openalex/2020.other.000102